Marché d’injection de douleurs articulaires – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00003536
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 162
Buy Now

[Rapport de recherche]Le marché des injections pour douleurs articulaires devrait atteindre 6 996,88 millions de dollars US d'ici 2028, contre 3 667,45 millions de dollars US en 2020 ; on estime qu'il croîtra à un TCAC de 8,5 % au cours de la période 2021-2028.



Les injections de douleurs articulaires procurent un soulagement plus rapide des douleurs intenses et réduisent l'inflammation des articulations. Plusieurs types d'injections disponibles sur le marché comprennent les injections de corticostéroïdes, les injections d'acide hyaluronique (HA), les injections de plasma riche en plaquettes (PRP) et les injections de matrice tissulaire placentaire (PTM). La croissance du marché de l'injection de douleurs articulaires est attribuée à des facteurs tels que la prévalence élevée de troubles musculo-squelettiques et le nombre croissant de blessures sportives. Cependant, les coûts élevés des thérapies de réparation articulaire entravent la croissance du marché. >

Les troubles musculo-squelettiques sont des affections médicales affectant les muscles, les os et les articulations du cou, des épaules, des poignets, du dos, des hanches, des jambes, des genoux et des pieds. Ces maladies comprennent la tendinite, le syndrome du canal carpien, l'arthrose, la polyarthrite rhumatoïde (PR), la fibromyalgie et les fractures osseuses. Selon la fiche d'information de l'Organisation mondiale de la santé (OMS) mise à jour en 2018, les troubles musculo-squelettiques sont le deuxième contributeur au handicap dans le monde. Selon la même étude, la prévalence et l'impact des troubles musculo-squelettiques devraient augmenter avec l'augmentation de la population vieillissante et l'augmentation de la prévalence des facteurs de risque des maladies non transmissibles (MNT) dans le monde. Selon les données de la réunion annuelle de l'American Academy of Orthopaedic Surgeons de 2016, environ 1 adulte sur 2 souffre d'un trouble musculo-squelettique aux États-Unis. De plus, selon les Centers for Disease Control and Prevention (CDC), l'arthrite provoque des douleurs intenses qui affectent chaque année des millions de personnes aux États-Unis. Environ un patient arthritique sur quatre, c'est-à-dire environ 15 millions sur un total d'environ 54 millions de patients, souffre de douleurs articulaires sévères liées à l'arthrite.



De plus, l'arthrose (OA) est l'un des troubles articulaires les plus courants dans le US, causée par la dégradation du cartilage articulaire entre les os. Elle est également connue sous le nom de maladie dégénérative des articulations ou « usure normale ». arthrite. Selon les Centers for Disease Control and Prevention (CDC), plus de 32,5 millions d'adultes aux États-Unis souffrent d'arthrose. De même, selon le National Health Service (NHS), plus de 10 millions de personnes au Royaume-Uni souffrent d'arthrite ou d'autres affections similaires qui affectent les articulations. Selon la Bupa Health Insurance, l'arthrose est la forme d'arthrite la plus répandue au Royaume-Uni, elle touche environ un tiers des personnes âgées de 45 ans ou plus dans le pays, soit environ 8,75 millions de personnes. Par conséquent, une prévalence aussi élevée de troubles musculo-squelettiques dans différents pays augmente le nombre de procédures de traitement effectuées pour les mêmes, entraînant ainsi la croissance du marché de l'injection de douleurs articulaires.



Insights basés sur les médicaments



< p>Le marché de l'injection de douleurs articulaires, par médicament, est segmenté en acide hyaluronique, corticostéroïde et autres. Le segment des corticostéroïdes détenait la plus grande part du marché en 2020, et il devrait en outre enregistrer le TCAC le plus élevé au cours de la période de prévision.



Marché de l'injection de douleur articulaire, par médicament - 2020 et 2028



Informations basées sur le type d'articulation



En fonction du type d'articulation, le marché de l'injection de douleurs articulaires est segmenté en genou, pied et cheville, épaule et coude, hanches et autres applications. Le segment du genou détenait la plus grande part de marché en 2020 et devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Insights basés sur le canal de distribution



Sur la base du canal de distribution, le marché de l'injection de douleurs articulaires est segmenté en pharmacies de détail, pharmacies hospitalières et autres. Le segment des soins des plaies détenait la plus grande part de marché en 2020, et le segment des greffes osseuses devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Perspectives stratégiques



Lancements de produits et les approbations sont les stratégies couramment adoptées par les entreprises pour étendre leur empreinte mondiale et leurs portefeuilles de produits. De plus, les acteurs du marché de l'injection de douleur articulaire se concentrent sur la stratégie de collaboration pour élargir leur clientèle, ce qui, à son tour, leur permet de maintenir leur marque à l'échelle mondiale.



Marché de l'injection de douleur articulaire - par médicament




  • Acide hyaluronique

  • Corticostéroïde

  • Autres

Marché de l'injection de douleur articulaire - par type d'articulation




  • Genou

  • Pied et Cheville

  • Épaule et Coude

  • Hanche

  • Autres

Marché de l'injection de douleur articulaire - par canal de distribution




  • Pharmacies de détail

  • Pharmacies d'hôpitaux

  • Autres

Pharmacies Marché de l'injection de douleur - par géographie




  • Amérique du Nord

    • États-Unis

    • Canada

    • Mexique


  • Europe

    • France

    • Allemagne

    • Italie

    • Royaume-Uni

    • Espagne

    • Reste de l'Europe


  • Asie-Pacifique (APAC)

    • Chine

    • Inde

    • Corée du Sud

    • Japon

    • Australie

    • Reste de l'Asie-Pacifique


  • Moyen-Orient et Afrique (MEA)< ul>
  • Afrique du Sud

  • Arabie saoudite

  • EAU

  • Reste du Moyen-Orient et Afrique

< li>Amérique du Sud et centrale (SCAM)

  • Brésil

  • Argentine

  • Reste de l'Amérique du Sud et centrale

< /ul>

Profils d'entreprise




  • Chugai Pharmaceutical Co., Ltd.

  • Bioventus Inc.

  • Fidia Pharma USA Inc.
  • Flexion Therapeutics, Inc.

  • SEIKAGAKU CORPORATION

  • Ferring BV

  • Sanofi

  • Anika Therapeutics, Inc.
  • Teva Pharmaceutical

  • OrthogenRx, Inc.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are joint pain injections?

Joint pain injections are medicinal fluids inserted in the patient’s body to get faster relief from severe pain. The joint pain injections are used to reduce inflammation in the joints. There are several types of injections available in the market which are corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections and placental tissue matrix (PTM) injections.

What are the driving factors for the joint pain injection market across the globe?

The global joint pain injection market growth is mainly attributed to factors such the high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, the high costs of joint repair therapies hinder the market growth.

Who are the major players in the joint pain injection market?

The joint pain injection market majorly consists of the players such as Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and OrthogenRx among others.

The List of Companies - Joint Pain Injection Market

  1. Chugai Pharmaceutical Co., Ltd.              
  2. Bioventus Inc.                
  3. Fidia Pharma USA Inc.                
  4. Flexion Therapeutics, Inc.          
  5. SEIKAGAKU CORPORATION       
  6. Ferring B.V.     
  7. Sanofi              
  8. Anika Therapeutics, Inc.             
  9. Teva Pharmaceutical                  
  10. OrthogenRx, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports